Researchers at WEHI have pinpointed the function of a potent cancer gene.
The gene, known as ERG, has long been associated with a range of human malignancies, including leukemia and sarcoma. American scientists showed in 2005 that ERG is mutated in more than half of all prostate cancers.
It was unclear, however, what function ERG normally performs in the human body and why it is so carcinogenic when mutated.
The team at WEHI has now demonstrated that ERGs usual role is to regulate the activity of blood stem cells. Without ERG, these cells cannot divide normally and the body fails to generate the trillions of blood cells that required each day to carry oxygen and fight infection.
The study suggests that ERG causes cancer by convincing normal cells to behave like stem cells, triggering unrestrained growth and expansion.
The findings offer hope that the targets of ERG might now be open to identification, which in the future might lead to new drugs that shut down the proliferation of cancer cells.
|Contact: Brad Allan|